[Pathogenesis, prophylaxis and therapy of hemostatic disorders in congenital cardiopathies].
D000138:Acidosis / Q000209:etiology; D000328:Adult; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D006348:Cardiac Surgical Procedures; D003490:Cyanosis / Q000097:blood / Q000201:enzymology / Q000453:epidemiology* / Q000209:etiology; D005112:Extracorporeal Circulation / Q000009:adverse effects; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006330:Heart Defects, Congenital / Q000601:surgery*; D006400:Hematocrit; D006470:Hemorrhage / Q000209:etiology; D006487:Hemostasis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D008297:Male; D008833:Microcirculation; D010958:Plasminogen / Q000032:analysis; D011183:Postoperative Complications; D013300:Streptokinase / Q000032:analysis; D013771:Tetralogy of Fallot / Q000097:blood; D013997:Time Factors
D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D013300:Streptokinase
Pathogenese, Prophylaxe und Therapie der Blutstillungsstörungen bei kongenitalen Kardiopathien.